chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Itching from top of chest to private parts; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching from top of chest to private parts) in a 94-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A, and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching from top of chest to private parts). At the time of the report, PRURITUS (Itching from top of chest to private parts) outcome was unknown. Not Provided          Concomitant medications were not reported. Treatment medication included unspecified skin cream.
COVID ARM WITH ITCHING,SWELLING,REDNESS NOT PAINFUL JUST AN ANNOYANCE PER PATIENT. PATIENT NOTICED FOUR DAYS AGO.
Hives (Wheels) on arms, legs and torso.  Had the Moderna Booster  Mild hives after 2nd vaccine of Moderna on 03/02/2021
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On an unknown date the patient was inadvertently vaccinated with a dose of ZOSTAVAX (dose, route and lot number not provided) as their booster dose for VARIVAX (Merck). No adverse events were reported. Additional information has been requested.
about 10 min after injection, complained of itching between shoulder blades below neck. appeared a little red from where he was scratching. injection site clear. no other problems. gave icepack. he said it didnt help much and requested benadryl. gave 25mg liquid benadryl  told to wait an additional 30 min to monitor. after 30 min says itching has subsided and feels better, just tired from the benadryl. His friend is driving him home.
after completing the two doses of Shingrix in 2018, patient experienced two episodes of shingles; Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of vaccination failure in a 70-year-old female patient who received Herpes zoster (Shingrix) (batch number Y24KE, expiry date 11th October 2020) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) (batch number HM3NC, expiry date 13th April 2021) for prophylaxis.   In July 2018, the patient received the 1st dose of Shingrix. In November 2018, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number Y2YKE and HM3MC were updated to Y24KE and HM3NC as per sale's data sheet. The reporter stated that, after vaccination with 2 doses of Shingrix, the patient experienced shingles. The reporter stated that, the patient experienced 2 episode of Shingles. The reporter was wondering if th patient could administer a third dose of Shingrix. The reporter consented to follow up. This case was considered as suspected vaccination failure, since time to onset and the details regarding laboratory confirmation for shingles were not provided
pt recvd vax on 13SEP92 & devel massive hair loss; No further details were provided;
Brain feels like freaking jellyfish; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Brain feels like jellyfish) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   In December 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Brain feels like jellyfish). At the time of the report, FEELING ABNORMAL (Brain feels like jellyfish) outcome was unknown.            No Concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
After administering vaccination, patient presented to the pharmacy a week later with obvious swelling in her left arm. Patient states that she received an x-ray to see if bone was hit at time of vaccination, which returned negative. Patient was prescribed triamcinolone cream to put on the site of swelling by her primary care physician.
102 fever-2 days Intense lower center abdominal pain-7 days Body ache-3 days Diarrhea-7 days Headache-5 days Low blood pressure-3 days Irregular hearbeat-7 days Light-headed-5 days "Covid arm" extending elbow to shoulder-back of arm to front of arm-3 days
Extreme fatigue, very sore injection site(could not raise my arm), generalized muscle aches, slight headache,slight nausea. It began at 12:30 am in the morning with waking up in a sweat then upon waking up in the next few hours, I felt as though I had the flu(have had 3 times in  my life). I barely had enough energy to walk-no appetite. I had taken Tylenol in the morning  which didn't help but then started taking Mortin (200 mg)and Benadryl(25 mg.)at 4pm. I took another dose of those at 8pm. I awoke the next morning at 5am with none of the symptoms from the day before except being slightly tired.
This case was reported by a pharmacist via call center representative and described the occurrence of therapy non-responder in a 39-year old female patient who received ENGERIX B adult (batch number ZR2M5, expiry date 16th April 2018. Co-suspect products included ENGERIX B adult (batch number 79ZS7, expiry date 4th June 2018) and ENGERIX B adult (batch number A9LB7, expiry date 7th July 2018). On an unknown date, the patient received the 1st dose of ENGERIX B adult (intramuscular) 1 ml and the 2nd dose of ENGERIX B adult (intramuscular) 1 ml. On 28th June 2016, the patient received the 3rd dose of ENGERIX B adult (intramuscular) 1 ml. On 28th June 2016, not applicable after receiving ENGERIX B adult and ENGERIX B adult and an unknown time after receiving ENGERIX B adult, the patient experienced drug dose administration interval too short. On 31st August 2016, the patient experienced therapy non-responder. On an unknown date, the patient experienced pharmaceutical product complaint. On an unknown date, the outcome of the therapy non-responder, drug dose administration interval too short and pharmaceutical product complaint were unknown. It was unknown if the report considered the therapy non-responder to be related to ENGERIX B adult, ENGERIX B adult and ENGERIX B adult. Additional details were provided as follows: The reporting pharmacist was the dispensing pharmacist. The age at vaccination was not reported. The regimen used was 3 doses on a schedule of 0, 4 weeks and 12 weeks later. On 28th June 2016, the patient received 3rd dose of ENGERIX B adult, which led to shortening of the vaccination schedule. The patient who was a healthcare worker at the facility received 3 doses of ENGERIX B adult in her deltoid. On 31st August 2016, 64 days after receiving 3rd dose of ENGERIX B adult , the patient underwent laboratory test, which showed anti-HBsAG level less than 10 mlU/ml drawn. There were 2 more healthcare workers at the facility (US2016128146 and US2016GSK131991), who had experienced the same outcome after three doses of ENGERIX-B.
This is a spontaneous report from a contactable pharmacist. This pharmacist reported for a 74-years-old female patient that received PREVNAR 13, single dose. On unknown date the patient experienced a swollen, tender, warm red reaction all over her arm. It is about 6 inches in diameter and is widely spread. The pharmacist thinks it looks like cellulitis but he is unable to diagnose her. She had the injection a week ago and the reaction has gradually got worse.
patient presented to emergency department 7/1/2021 with flu-like illness for approximately 1 week. He had fever, chills and cough. Requiring  O2 at 2-3 LPM.  Treating with dexamethasone 6mg daily, supplemental O2 and SQ heparin for VTE prophylaxis.
17 year old vaccinated with the Moderna COVID 19 vaccine; A spontaneous report  was received from a dentist concerning a 17 years-old, female patient who was received the Moderna COVID 19 vaccine and product administered to patient of inappropriate age.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   The patient received their first of two planned doses of mRNA-1273 (Lot # not provided) (route of administration and injection site not provided) on 05 Jan 2021 for prophylaxis of COVID-19 infection.  On 05 Jan 2021, a 17 years-old patient was vaccinated with the Moderna COVID-19 vaccine. The patient's father (dentist) was asking for guidance as both of his daughters were vaccinated but only one of them received the second dose as the local health department did not allow one to get the second dose. Reporter also inquired about time of appearance of the side effects.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of event 17 year old vaccinated with the Moderna COVID 19 vaccine was unknown.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273.  There were no reported adverse events associated with this case.
Was very sick for a day; Really bad diarrhea for 12 hours; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Was very sick for a day), DIARRHOEA (Really bad diarrhea for 12 hours) and NAUSEA (Nausea) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine. Concomitant products included TIZANIDINE for Migraine, TRAZODONE for Sleep disorder, OXYBUTYNIN CHLORIDE, TOPIRAMATE, MONTELUKAST SODIUM, ALPRAZOLAM, PANTOPRAZOLE SODIUM, ARIPIPRAZOLE, DESVENLAFAXINE SUCCINATE MONOHYDRATE (PRISTIQ), ESTRADIOL, VALPROATE SEMISODIUM (DIVALPROEX), GABAPENTIN, TRAMADOL and PRAZOSIN for an unknown indication.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced ILLNESS (Was very sick for a day), DIARRHOEA (Really bad diarrhea for 12 hours) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, ILLNESS (Was very sick for a day), DIARRHOEA (Really bad diarrhea for 12 hours) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-242179 (Patient Link).
05/12/2003: Following TD-Had ivory to back of leg-backed up into pain on 05/11/2003.   05/13/2003: All day could move freely and pain until 10 pm-couldn't move at all and throbbing all night.  05/14/2003: Came in to be checked-slightly pink.  Received Tylenol or Ibuprofen can put warm compresses-keep moving arm -call or see MD if worsening.
pt recv vax;became pale & listless;T 95.6;pt began frothing & foaming at the mouth;seemed to have trouble breathing;turned blue, eyes rolled back & limbs hung stiff; anaphylactic shock;
Pt presented with onset 1 week post flu shot with severe body muscle/joint pain bilateral lasting for approx. 4-5 days. Labs normal. Question relation to vaccine.
Swelling of arm and hardness at the injection site with redness and heat. This was followed during the night by swelling of the entire upper arm with redness, heat, and muscular discomfort. By the next evening there was a band of red inflammation of about 2" in width circling the lower bicep that was swollen above the already swollen arm. This was accompanied by difficulty using the arm as well as some localized itching. This lasted for 3 days. However the itching has continued throughout various parts of my body with no set pattern. Sometimes there are hives or welt or red streaks. The areas affected the worst are the palms of my hands, between the fingers, scalp, chin, shins, and back of my neck. It is slowly resolving but at times is extremely uncomfortable.
This spontaneous case reported by a consumer, describes the occurrence of pain, pain in extremity (flare-up and pain on bottom of right foot) and back pain (pain in back) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included gout. On Mar 2, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Mar 4, 2021, patient experienced pain, pain in extremity (flare-up and pain on bottom of right foot) and back pain (pain in back). The patient treated with Tylenol (paracetamol), at an unspecified dose and frequency. At the time of the report, pain, pain in extremity (flare-up and pain on bottom of right foot) and back pain (pain in back) outcome: unknown. No concomitant medications provided. Action taken with mRNA-1273 in response to the event: not applicable.
pain; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a 77-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 24th June 2022, the patient received Shingles vaccine. In June 2022, less than a week after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   The reporter considered the pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 25-JUN-2022 Reporter's Comments: This case was reported by patient's mate via interactive digital media. The reporter reported that the patient had pain from the Shingles vaccine which was received yesterday (the day before reporting). The reporter asked what he/she should do. Additional Supportive Information: The follow-up would not possible as no contact details were available.
Information has been received from a physician concerning a male patient between the age of 8-12 years old who on unspecified dates was vaccinated with two doses of VARIVAX (Merck) (lot#s not reported). On an unspecified date in 2004 the patient came down with full blown chickenpox. Unspecified medical attention was sought. At the time of this report, the patient had recovered. This is one of several reports from the same source. Additional information has been requested.
numbness and tingling in all four extremities; numbness and tingling in all four extremities; intermittent weakness in my hands, arms and legs; This is a spontaneous report from a contactable healthcare professional  (patient).  A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: EL0140), via an unspecified route of administration on the left arm on 18Dec2020 12:30 at SINGLE DOSE for COVID-19 immunization at the hospital. Medical history reported as none and the patient had no known allergies. The patient's concomitant medications were not reported.  It was mentioned that prior to vaccination, the patient was not diagnosed with COVID-19 and had not been tested for COVID-19 since vaccination. On 19Dec2020 13:30, the patient was experiencing numbness and tingling in all four extremities after the first dose of the vaccine. The patient also experienced intermittent weakness in hands, arms and legs. It was also mentioned that the patient had numbness and tingling in all four extremities for the past 10 days. The patient did not receive any treatment for the events. Outcome of the events were unknown.
I started developing a lump at the vaccination site on my left arm the next day. It was very painful, red, swollen and had a big lump. I also started getting itchy there too. My arm was a lot more painful than I've ever experienced from any other vaccines such as the flu shot. I also have never had a reaction to one before. 2 days later I was in the express care for my daughter and had the PA look at it and he said if it doesn't get better by Monday (12/28) call my primary care physician. Monday came around and it started getting better, so I didn't call, by Wednesday it continued to get better but not completely gone. Thursday (12/31) I developed a lump again, painful, swelling, red patch at the injection site, hot to the touch. I had a virtual visit with my primary care physician and he said I'm having an allergic reaction at the vaccination site. He prescribed me 3 days of Prednisone 50mg/day, Claritin 2x daily & Pepcid 2x daily all for 3 days. It has finally resolved now.
Patient had severe vomiting and fever 11/15, 11/16, 11/17. He had an emergency appendectomy 11/18.
Listed above is the first round, the 2nd round was on 02/27/2021. I have some COVID like symptoms after both, mostly just tiredness. Now a week or two after the 2nd shot, I'm having significant shortness of breath after very little exertion. I did NOT have breathing issues when I had the COVID back in NOVEMBER. I called my Doctor on 03/15/2021 and he prescribed WIXELA and MONTELUKAST , so far though and it's only been a few days, I see no improvement. I just felt like since it might be COVID related, I should at least let someone know about it. I feel fine other than when I do minor physical stuff, even tying my shoes will leave me gasping for air.
Site: Pain at Injection Site-Severe, Additional Details: Patient complains of extreme muscle pain at site of reaction. Stated he had site pain on the day of the injection. The following day he was unable to move his arm. Today he stated that he can move his arm up and down but can not move side to side. When asked, patient stated he does not feel shoulder pain or discomfort and specified it felt like muscle pain specifically at site of injection. Patient was advised to treat pain with acetaminophen and make an appointment to be checked out.
This spontaneous report was received from a register nurse concerning an unspecified number of patients of an unknown age and gender that were vaccinated with a dose of VARIVAX (Merck) (dose, dose number, lot number, expiration date, and route were not reported), that were improperly stored. No adverse effects reported. Medical history and concurrent conditions of the patients were not reported. Co-suspect and concomitant therapies were not reported. These is one (1) of three (3) reports from the same source. Additional information has been requested.
Continued symptoms 3 days after last dose; Continued symptoms 3 days after last dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 94-year-old male patient received BNT162b2 (BNT162B2), on 15Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 93 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing), notes: heart disease; "heart disease" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing). There were no concomitant medications within 2 weeks after vaccination. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "recovering" and all described as "Continued symptoms 3 days after last dose". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received treatment of Covid-19 from 07Jul2022 to 12Jul2022.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On October 11th, 4 days after my Booster Shot my body started to break out in Hives and swelling of tissue under my skin also instances of swelling of my bottom lip. The Hives move around my body and are itchy and currently there are more hives present. This has been occurring everyday since Oct 11th.
Moderns Covid-19 Vaccine EUA adverse reaction included: the following symptoms started within 16-18 hours after injection: severe body aches, severe headache, extreme exhaustion that kept me bedridden for at least 2 days but lingered 2 more days after that; no appetite (slight nausea), unknown if I had fever, This reaction to the vaccine was worse than when I actually had Covid previously. 3 days after the shot I had moderate bouts of diarrhea in the morning and lingering lack of appetite and fatigue. Did not feel back to my normal self until 5 days later. I will NOT be getting the second dose because of this reaction
She started with heaviness in her arm that moved to her anterior chest wall on that same side. She then developed a fever up to 100.8. She has been unable to lift that L arm due to intense pain. She has been feeling ill and has had a low grade headache and the fever spike again this morning headache
Swelling on the left collar area; This is a spontaneous report received from a contactable consumer, the patient. A 43-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 16Mar2021 at 14:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via unspecified route of administration on 23Feb2021 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination the patient was not diagnosed with COVID-19. Medical history and concomitant medication were not reported. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient reported no allergies to medications, food, or other products. On 17Mar2021, the patient experienced there was swelling on her left collar area was sensitive to touch. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the event. The clinical outcome of swelling was not recovered at the time of this report.   Information about lot/batch number cannot be obtained. No further information expected.
Was to receive SARS-2-COVID booster dose of 0.25ml instead received 0.50ml dose. States arm was a little sore and there was a small bump for a few days after, no other symptoms reported.